Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kapil Kole
Institution:
Shivaji University
Observed institution:
Shivaji University
ORCID:
0009-0004-6870-1214
Observed ORCID:
0009-0004-6870-1214
OpenAlex ID:
A5079762810
Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer
2022
·
Popat Kumbhar
, Kapil Kole
, et al.
·
Journal of Controlled Release
·
40
Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications
2022
·
Popat Kumbhar
, Kaustubh Kolekar
, et al.
·
Journal of Controlled Release
·
32
Drug repurposing: An emerging strategy in alleviating skin cancer
2022
·
Popat Kumbhar
, Kapil Kole
, et al.
·
European Journal of Pharmacology
·
30
Drug Repurposing Opportunities in Cancer
2023
·
Popat Kumbhar
, Kapil Kole
, et al.
·
Springer eBooks
·
6
Formulation of repurposed celecoxib-loaded nanostructured lipid carriers using Box-Behnken design, its characterization, and anticancer evaluation
2025
·
Ashwini Bhavar
, Kaustubh Ajit Kolekar
, et al.
·
Annales Pharmaceutiques Françaises
·
5
Development of repurposed simvastatin-loaded nanostructured lipid carriers using Box Behnken design, its characterization, and anticancer evaluation
2026
·
Tejashree Yadav
, Kaustubh Ajit Kolekar
, et al.
·
Next research.
Show more works
View as search
Works count:
6
Citation count:
113
H-index:
5
I10-index:
3
Year
Topic
Type
